alt text alt text


Anteris Technologies Ltd is a publicly listed company on the Australian Securities Exchange under the ASX code AVR

stock stock
  • AVR:
  • /



Breaking News

US FDA grants DurAVR™ THV
approval for Early Feasibility Study (EFS)

November 2022

ASX Announcement
tile2 Desktop image tile1 mobile

PCR London Valves: Expert Interview

DurAVR THV Impact of Novel Leaflet Design on Hemodynamics and Physiology

Presented by:

Faculty: Bernard Prendergast, MD
Joao Cavalcante, MD, and Chris Meduri, MD
Watch Here
tile3desktop mobtile3

PCR London Valves: Late Breaking Clinical Trial

DurAVR THV First-in-Human Study, 30-day Results
Presented by Chris Meduri, MD
Karolinska University Medical Center, Sweden


View Here
tile4 desktop mobtile4

PCR London Valves: Rapid Fire Abstract

DurAVR THV Novel Leaflet Design Restores Aortic Flow and Hemodynamics on Cardiac MRI Analysis
Presented by Pankaj Garg, MD
University of East Anglia, United Kingdom


View Here






2021 Annual Report


alt text






Analyst Reports


  •    Evolution Capital November 2022 Report Download
  •    Bioshares October 2022 Report Download
  •    Evolution Capital October 2022 Report Download
  •    Bioshares September 2022 Report Download
  •    Bioshares August 2022 Report Download
  •    AVR Desk Note - Volte Corporate Download
  •    Bioshares November 2020 Report Download
  •    Bioshares July 2020 Report Download
  •    Bioshares June 2020 Report Download








Type: Price Sensitive Only
Date Announcement Reference
Showing - of
No results

Corporate Governance

Anteris Technologies Ltd ABN 35 088 221 078 (“Company”) has adopted comprehensive systems of control and accountability as the basis for the administration of Corporate Governance. The Board of the Company is committed to administering the policies and procedures with openness and integrity, pursuing the true spirit of Corporate Governance commensurate with the Company’s needs.
Anteris Technologies Ltd complies with the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations 4th Edition. For more information about how we comply, please see our Corporate Governance Statement.
The Corporate Governance principles adopted establish the framework for how the Board carries out its duties and obligations on behalf of shareholders.
Anteris Technologies Ltd's Corporate Governance Framework is underpinned by a range of Board-endorsed policies and procedures.

Board of Directors

John Seaberg
Wayne Paterson
Managing Director/CEO
Stephen Denaro
Non-Executive Director and Company Secretary
Dr Wenyi Gu
Non-Executive Director

Executive Management Board

Wayne Paterson
Managing Director/CEO
David St Denis
Chief Operating Officer
Matthew McDonnell
Chief Financial Officer





Share Registry

Computershare Investor Services Pty Ltd

Level 1, 200 Mary Street
Brisbane, QLD 4000
T 1300 850 505 (within Australia)
T +61 3 9415 4000 (outside Australia)
F 1800 783 447 (within Australia)
F +61 3 9473 2555 (outside Australia)
ComputerShare Investor Services manages our share registry. You can contact them for details about your holding here.
A copy of our recent top 20 shareholder list is available here.

For Holders of Unlisted Options

View More




   Anteris Technologies Ltd

      ABN 35 088 221 078



Brisbane – Registered Office

Toowong Tower

Suite 302, Level 3, 9 Sherwood Rd

Toowong, Queensland 4066

PO Box 1159, Milton 4064 

T +61 (0)7 3152 3200

F +61 (0)7 3152 3299


Perth - Manufacturing

26 Harris Rd

Malaga WA 6090



Minneapolis - Corporate Office

860 Blue Gentian Road

Suite 340

Eagan MN 55121

United States Customer Service

T +1 651 493 0606




Rte de Pré‑Bois 20

PO BOX 1877

1215 Geneva 15


Customer Service:

T +41 22 575 6746